Results 351 to 360 of about 348,390 (367)

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

Nature, 2011
Stephen J Sawcer, Garrett Hellenthal, Matti Pirinen   +2 more
exaly  

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

Nature Genetics, 2013
Sergio E Baranzini, Ingrid Kockum, Chris Cotsapas   +2 more
exaly  

A regenerative approach to the treatment of multiple sclerosis

Nature, 2013
Virginie Tardif, Costas A Lyssiotis, Krishnan Padmanabhan   +2 more
exaly  

Axonal loss in the multiple sclerosis spinal cord revisited

Brain Pathology, 2018
Natalia Petrova, Daniele Carassiti, David Baker   +2 more
exaly  

Progressive multiple sclerosis: from pathophysiology to therapeutic strategies

Nature Reviews Drug Discovery, 2019
Jason R Plemel, Simon Faissner, V Wee Yong   +2 more
exaly  

Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis

Cell, 2018
Ivan Jelcic, Faiez Al Nimer, Verena Lentsch   +2 more
exaly  

Medical marijuana for cancer

Ca-A Cancer Journal for Clinicians, 2015
exaly  

Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination

Glia, 2017
Verena Schultz, Christine Stadelmann, Pierangelo Metrangolo   +2 more
exaly  

Tuberous Sclerosis

Archives of Ophthalmology, 1992
openaire   +2 more sources

Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab

Nature Reviews Drug Discovery, 2005
exaly